Neurovigil, Inc. Industries
-
Clinical Services
-
-
Medical / Health Care
-
-
NeuroVigil enables pharmaceutical companies to use EEG recordings to analyze drug efficacy and screen for biomarker data indicating neuropathologies.
Two billion people worldwide are affected by a brain or nervous system disorder, including 100 million in America. NeuroVigil`s non-invasive, wireless window into the brain maps brain activity and can offer insight into the diagnosis and treatment of conditions such as Alzheimer`s, autism, cancer, epilepsy, depression, and schizophrenia. NeuroVigil technology is currently utilized in major universities and pharmaceutical companies to provide brain analyses of subjects throughout research studies and trials.
Seventy million Americans have sleep disorders causing apnea, fatigue, depression, and minor to severe accidents. These disorders can also be indicators of disease or trauma. NeuroVigil`s technologic advance dramatically improves the quality and lowers the costs of sleep testing. Our technology not only automates current manual tasks, but also more than quadruples the amount of useful information obtained from current EEG data, which leads to neural signatures, or correlates of important disease states, that...